Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Acta Dermato-Venereologica|November 22, 2021
Common Fundamentals of Psoriasis and DepressionStefanie Hölsken, Frederik Krefting, Manfred Schedlowski, et al.
Acta Dermato-Venereologica|March 14, 2024
Discontinuation of Fumaric Acid Esters is Affected by Depressive Symptomatology: A Retrospective AnalysisFrederik Krefting, Stefanie Hölsken, Manfred Schedlowski, et al.
BMJ Open|September 3, 2021
Expectation-induced enhancement of pain, itch and quality of life in psoriasis patients: study protocol of a randomised controlled trialStefanie Hölsken, Frederik Krefting, Manfred Schedlowski, et al.
Journal of Vision|May 26, 2021
Individual differences in crowding predict visual search performanceInês S Veríssimo, Stefanie Hölsken, Christian N L Olivers
Journal of the European Academy of Dermatology and Venereology : JEADV|June 16, 2023
How familiar are German dermatologists with placebo and nocebo effects and to what extent are these targeted in clinical practice: A survey within the dermatological communityFrederik Krefting, Stefanie Hölsken, Sven Benson, et al.
Dermatologie (Heidelberg, Germany)|May 9, 2023
[Randomized clinical trial of compression therapy of the lower legs in patients with psoriasis]Frederik Krefting, Stefanie Hölsken, Maurice Moelleken, et al.
The Journal of Dermatology|November 22, 2021
A brief screening tool for depression in psoriasis patients: The Two Questions Test in clinical practiceStefanie Hölsken, Frederik Krefting, Lea Schneider, et al.
Psoriasis (Auckland, N.Z.)|January 15, 2025
Shaping Treatment Expectation to Optimize Efficacy of Interleukin 17A Antagonist Secukinumab in Psoriasis PatientsStefanie Hölsken, Frederik Krefting, Senta Mühlhaus, et al.
Patient Preference and Adherence|July 1, 2024
"I Was Almost in Disbelief" - Qualitative Analysis of Experiences and Expectations Among Psoriasis Patients Undergoing Biologic Treatment with SecukinumabStefanie Hölsken, Carina Benthin, Frederik Krefting, et al.
Pageof 2